ERAS-5024   Click here for help

GtoPdb Ligand ID: 12988

Synonyms: compound 14 [PMID: 37849557] | ERAS5024
Compound class: Synthetic organic
Comment: ERAS-5024 was designed to target the KRAS G12D mutation in pancreatic ductal adenocarcinoma (PDAC) [2]. In vivo activity in PDAC xenograft mouse models suggested clinical potential. However, development was discontinued due to toxicity (histamine release and a pseudo-allergic reaction) caused by off-target agonist activity at the orphan GPCR, MAS related GPR family member X2 (MRGPRX2) [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 127.57
Molecular weight 673.68
XLogP 2.78
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1C[C@]2(C[C@H](CN2C1)F)COC3=NC(=C4C=C(C(=C(C4=N3)F)C5=CC=C(C6=C5C(=C(N)S6)C#N)F)C(F)(F)F)N7CC8CCC(C7)N8
Isomeric SMILES NC1=C(C#N)C2=C(C=CC(F)=C2S1)C3=C(F)C4=NC(OC[C@@]56CCCN5C[C@H](F)C6)=NC(N7CC8CCC(C7)N8)=C4C=C3C(F)(F)F
InChI InChI=1S/C32H29F6N7OS/c33-15-9-31(6-1-7-45(31)11-15)14-46-30-42-26-19(29(43-30)44-12-16-2-3-17(13-44)41-16)8-21(32(36,37)38)24(25(26)35)18-4-5-22(34)27-23(18)20(10-39)28(40)47-27/h4-5,8,15-17,41H,1-3,6-7,9,11-14,40H2/t15-,16?,17?,31+/m1/s1
InChI Key KFVWCOMHUKVKIB-LDKIVBMGSA-N
References
1. Brooun A, Zhang J, Li C, Lam R, Cheng H, Shoemaker R, Daly J, Olaharski A. (2023)
The pharmacologic and toxicologic characterization of the potent and selective KRAS G12D inhibitors ERAS-4693 and ERAS-5024.
Toxicol Appl Pharmacol, 474: 116601. [PMID:37321326]
2. Cheng H, Li P, Chen P, Irimia A, Bae JH, Brooun A, Fagan P, Lam R, Lin B, Zhang J et al.. (2023)
Structure-Based Design and Synthesis of Potent and Selective KRAS G12D Inhibitors.
ACS Med Chem Lett, 14 (10): 1351-1357. [PMID:37849557]